Stifel Nicolaus Keeps Their Buy Rating on Iovance Biotherapeutics (IOVA)
In a report released today, Benjamin Burnett from Stifel Nicolaus maintained a Buy rating on Iovance Biotherapeutics (IOVA – Research Report), ...